Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.0K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.0K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

134.0K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
134.0K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

284
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
284

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Schroeder van der Kolk and Capgras's delusion].

Tijdschrift voor psychiatrie·2025
Same author

Rapid effects of deep brain stimulation reactivation on symptoms and neuroendocrine parameters in obsessive-compulsive disorder.

Translational psychiatry·2016
Same author

Net gain analysis, an addition to responder analysis--The case of antipsychotic treatment of acute mania.

Regulatory toxicology and pharmacology : RTP·2015
Same author

Efficacy of drug treatment for acute mania differs across geographic regions: An individual patient data meta-analysis of placebo-controlled studies.

Journal of psychopharmacology (Oxford, England)·2015
Same author

Placebo response in antipsychotic trials of patients with acute mania: Results of an individual patient data meta-analysis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2015
Same author

[The 'signe du miroir'. Psychopathological reflections on a forgotten phenomenon].

Tijdschrift voor psychiatrie·2014

Related Experiment Video

Updated: Mar 24, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.9K

The tyramine conjugation test and depression.

J G Storosum, F de Jonghe, H F Schalken

    Acta Neuropsychiatrica
    |March 9, 2016
    PubMed
    Summary

    The tyramine conjugation test (TCT) shows promise in predicting antidepressant response. This simple test may also identify a vulnerability to depression, though its exact cause requires further study.

    Area of Science:

    • Psychiatry and Pharmacology
    • Biochemical Markers in Mental Health

    Background:

    • Depression's etiology remains complex and multifactorial.
    • Predicting individual response to antidepressant medication is a significant clinical challenge.
    • Tyramine metabolism may play a role in mood disorders.

    Purpose of the Study:

    • To review the utility of the tyramine conjugation test (TCT) as a predictive biomarker for antidepressant treatment efficacy.
    • To explore the potential of TCT in identifying individuals vulnerable to depression.
    • To examine hypotheses regarding the underlying causes of altered tyramine conjugation.

    Main Methods:

    • Review of existing literature on the tyramine conjugation test (TCT).
    • Analysis of TCT's performance characteristics (sensitivity, specificity) as a predictor.

    More Related Videos

    Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
    12:21

    Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

    Published on: November 27, 2016

    15.6K
    The Forced Swim Test as a Model of Depressive-like Behavior
    05:42

    The Forced Swim Test as a Model of Depressive-like Behavior

    Published on: March 2, 2015

    40.4K

    Related Experiment Videos

    Last Updated: Mar 24, 2026

    A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
    07:56

    A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

    Published on: August 11, 2021

    3.9K
    Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
    12:21

    Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

    Published on: November 27, 2016

    15.6K
    The Forced Swim Test as a Model of Depressive-like Behavior
    05:42

    The Forced Swim Test as a Model of Depressive-like Behavior

    Published on: March 2, 2015

    40.4K
  • Examination of studies investigating tyramine conjugation in relation to depression vulnerability.

    • Main Results:

    • The tyramine conjugation test (TCT) is suggested to be a sensitive and specific predictor of antidepressant response.
    • The test is minimally invasive, easy to administer, and well-tolerated by patients.
    • Evidence indicates that reduced tyramine conjugation may serve as a trait marker for depression vulnerability.

    Conclusions:

    • The tyramine conjugation test (TCT) holds potential as a valuable tool in personalized antidepressant pharmacotherapy.
    • Further research is warranted to elucidate the unclear etiology of decreased tyramine conjugation and its implications.
    • TCT may aid in identifying individuals at risk for developing depression.